Cargando…

Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan

PURPOSE: Given the chronic shortage of blood for transfusion in Japan, promotion of appropriate use of fresh frozen plasma (FFP) urgently needs to be addressed by the national blood project in Japan. Whether FFP transfusions are administered appropriately in Japan is currently unclear. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Aya, Fujii, Teruhisa, Okikawa, Yoshiko, Sasaki, Fumie, Okajima, Masazumi, Hidaka, Hidekuni, Iwato, Koji, Sato, Kazuyoshi, Kokubunji, Akira, Takata, Noboru, Yamamoto, Masahiro, Tanaka, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594890/
https://www.ncbi.nlm.nih.gov/pubmed/34803417
http://dx.doi.org/10.2147/JBM.S338556
_version_ 1784600079131213824
author Sugiyama, Aya
Fujii, Teruhisa
Okikawa, Yoshiko
Sasaki, Fumie
Okajima, Masazumi
Hidaka, Hidekuni
Iwato, Koji
Sato, Kazuyoshi
Kokubunji, Akira
Takata, Noboru
Yamamoto, Masahiro
Tanaka, Junko
author_facet Sugiyama, Aya
Fujii, Teruhisa
Okikawa, Yoshiko
Sasaki, Fumie
Okajima, Masazumi
Hidaka, Hidekuni
Iwato, Koji
Sato, Kazuyoshi
Kokubunji, Akira
Takata, Noboru
Yamamoto, Masahiro
Tanaka, Junko
author_sort Sugiyama, Aya
collection PubMed
description PURPOSE: Given the chronic shortage of blood for transfusion in Japan, promotion of appropriate use of fresh frozen plasma (FFP) urgently needs to be addressed by the national blood project in Japan. Whether FFP transfusions are administered appropriately in Japan is currently unclear. In this study, we aimed to investigate the outcomes of patients who undergo FFP transfusion and the appropriateness of use of FFP. PATIENTS AND METHODS: This multicentre, prospective, observational cohort study was conducted from September 2017 to April 2019 at the 15 medical institutions in Hiroshima Prefecture that are the top providers of FFP. All patients who underwent FFP transfusion during the study period were included, relevant data being extracted from the medical records. The indications for FFP transfusion were classified in accordance with the Guidelines of the Ministry of Health, Labour and Welfare of Japan. Factors associated with patient outcomes at day 28 after FFP transfusion were subjected to multivariable logistic regression analysis. RESULTS: In total, data of 1299 patients were eligible for analysis. At least 63.8% of indications for FFP were in accordance with the guideline for FFP transfusions. The mortality rate at day 28 after FFP transfusion was 16.2%. Older age (65–74 years: adjusted odds ratio [AOR]=4.3, ≥75 years: AOR=4.1), non-perioperative use (AOR=4.5), coagulopathy associated with liver damage (AOR=2.7), large volume of FFP transfused (AOR=2.5), and lack of improvement in blood coagulation following FFP transfusion were independently and significantly associated with death within 28 days after FFP transfusion. CONCLUSION: Our findings do not support the simple conclusion that FFP transfusions contribute to prognosis. However, given that coagulopathy in patients with end-stage liver disease is infrequently improved by FFP transfusion, “inappropriate” use of FFP should be avoided. It is important to promote appropriate use of FFP so as not to waste blood resources.
format Online
Article
Text
id pubmed-8594890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85948902021-11-18 Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan Sugiyama, Aya Fujii, Teruhisa Okikawa, Yoshiko Sasaki, Fumie Okajima, Masazumi Hidaka, Hidekuni Iwato, Koji Sato, Kazuyoshi Kokubunji, Akira Takata, Noboru Yamamoto, Masahiro Tanaka, Junko J Blood Med Original Research PURPOSE: Given the chronic shortage of blood for transfusion in Japan, promotion of appropriate use of fresh frozen plasma (FFP) urgently needs to be addressed by the national blood project in Japan. Whether FFP transfusions are administered appropriately in Japan is currently unclear. In this study, we aimed to investigate the outcomes of patients who undergo FFP transfusion and the appropriateness of use of FFP. PATIENTS AND METHODS: This multicentre, prospective, observational cohort study was conducted from September 2017 to April 2019 at the 15 medical institutions in Hiroshima Prefecture that are the top providers of FFP. All patients who underwent FFP transfusion during the study period were included, relevant data being extracted from the medical records. The indications for FFP transfusion were classified in accordance with the Guidelines of the Ministry of Health, Labour and Welfare of Japan. Factors associated with patient outcomes at day 28 after FFP transfusion were subjected to multivariable logistic regression analysis. RESULTS: In total, data of 1299 patients were eligible for analysis. At least 63.8% of indications for FFP were in accordance with the guideline for FFP transfusions. The mortality rate at day 28 after FFP transfusion was 16.2%. Older age (65–74 years: adjusted odds ratio [AOR]=4.3, ≥75 years: AOR=4.1), non-perioperative use (AOR=4.5), coagulopathy associated with liver damage (AOR=2.7), large volume of FFP transfused (AOR=2.5), and lack of improvement in blood coagulation following FFP transfusion were independently and significantly associated with death within 28 days after FFP transfusion. CONCLUSION: Our findings do not support the simple conclusion that FFP transfusions contribute to prognosis. However, given that coagulopathy in patients with end-stage liver disease is infrequently improved by FFP transfusion, “inappropriate” use of FFP should be avoided. It is important to promote appropriate use of FFP so as not to waste blood resources. Dove 2021-11-12 /pmc/articles/PMC8594890/ /pubmed/34803417 http://dx.doi.org/10.2147/JBM.S338556 Text en © 2021 Sugiyama et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sugiyama, Aya
Fujii, Teruhisa
Okikawa, Yoshiko
Sasaki, Fumie
Okajima, Masazumi
Hidaka, Hidekuni
Iwato, Koji
Sato, Kazuyoshi
Kokubunji, Akira
Takata, Noboru
Yamamoto, Masahiro
Tanaka, Junko
Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title_full Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title_fullStr Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title_full_unstemmed Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title_short Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan
title_sort outcomes of patients who undergo transfusion of fresh frozen plasma: a prospective, observational, multicentre cohort study in hiroshima, japan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594890/
https://www.ncbi.nlm.nih.gov/pubmed/34803417
http://dx.doi.org/10.2147/JBM.S338556
work_keys_str_mv AT sugiyamaaya outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT fujiiteruhisa outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT okikawayoshiko outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT sasakifumie outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT okajimamasazumi outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT hidakahidekuni outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT iwatokoji outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT satokazuyoshi outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT kokubunjiakira outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT takatanoboru outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT yamamotomasahiro outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan
AT tanakajunko outcomesofpatientswhoundergotransfusionoffreshfrozenplasmaaprospectiveobservationalmulticentrecohortstudyinhiroshimajapan